MX2019011517A - Proceso para producir analogos de anillo de arilomicina. - Google Patents

Proceso para producir analogos de anillo de arilomicina.

Info

Publication number
MX2019011517A
MX2019011517A MX2019011517A MX2019011517A MX2019011517A MX 2019011517 A MX2019011517 A MX 2019011517A MX 2019011517 A MX2019011517 A MX 2019011517A MX 2019011517 A MX2019011517 A MX 2019011517A MX 2019011517 A MX2019011517 A MX 2019011517A
Authority
MX
Mexico
Prior art keywords
making
arylomyin
ring analogs
ring
analogs
Prior art date
Application number
MX2019011517A
Other languages
English (en)
Inventor
Gosselin Francis
LINGHU Xin
Petronijevic Filip
Lim Ngiap-Kie
WONG Nicholas
Hong Allen
Hou Haiyun
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2019011517A publication Critical patent/MX2019011517A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D245/00Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
    • C07D245/02Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Métodos para hacer un anillo de arilomicina de la fórmula t (ver fórmula) o sales o solvatos del mismo, en donde R, R1, R2, R3, R4, R5, R6, R7, R8, R9, R5, R10 y Pg1 son como se definen en la presente.
MX2019011517A 2017-03-27 2018-03-26 Proceso para producir analogos de anillo de arilomicina. MX2019011517A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762477268P 2017-03-27 2017-03-27
PCT/US2018/024351 WO2018183198A1 (en) 2017-03-27 2018-03-26 Process for making arylomyin ring analogs

Publications (1)

Publication Number Publication Date
MX2019011517A true MX2019011517A (es) 2019-11-18

Family

ID=61913697

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019011517A MX2019011517A (es) 2017-03-27 2018-03-26 Proceso para producir analogos de anillo de arilomicina.

Country Status (16)

Country Link
US (2) US11192924B2 (es)
EP (1) EP3601240B1 (es)
JP (1) JP7041687B2 (es)
KR (1) KR102589474B1 (es)
CN (2) CN117777229A (es)
AU (2) AU2018243724B2 (es)
BR (1) BR112019020112A2 (es)
CA (1) CA3057997A1 (es)
ES (1) ES2892173T3 (es)
HR (1) HRP20211495T1 (es)
IL (1) IL269532B (es)
MX (1) MX2019011517A (es)
PL (1) PL3601240T3 (es)
SG (1) SG11201908932SA (es)
SI (1) SI3601240T1 (es)
WO (1) WO2018183198A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6873993B2 (ja) 2015-11-20 2021-05-19 アールキューエックス ファーマシューティカルズ,インク. 大環状広域抗生物質
WO2018149419A1 (en) 2017-02-15 2018-08-23 Rqx Pharmaceuticals, Inc. Macrocyclic broad spectrum antibiotics
HRP20231497T1 (hr) * 2019-05-28 2024-03-01 F. Hoffmann-La Roche Ag Makrociklični antibiotici širokog spektra

Also Published As

Publication number Publication date
SI3601240T1 (sl) 2021-11-30
AU2022218486A1 (en) 2022-09-08
CN110475766A (zh) 2019-11-19
US11192924B2 (en) 2021-12-07
HRP20211495T1 (hr) 2021-12-24
CN117777229A (zh) 2024-03-29
AU2018243724A1 (en) 2019-10-03
IL269532A (en) 2019-11-28
PL3601240T3 (pl) 2021-12-20
ES2892173T3 (es) 2022-02-02
US11702452B2 (en) 2023-07-18
AU2018243724B2 (en) 2022-07-28
EP3601240A1 (en) 2020-02-05
SG11201908932SA (en) 2019-10-30
WO2018183198A1 (en) 2018-10-04
CA3057997A1 (en) 2018-10-04
US20200255476A1 (en) 2020-08-13
KR20190133033A (ko) 2019-11-29
AU2022218486B2 (en) 2023-09-28
KR102589474B1 (ko) 2023-10-16
US20220056078A1 (en) 2022-02-24
IL269532B (en) 2021-12-01
BR112019020112A2 (pt) 2020-05-05
CN110475766B (zh) 2023-12-29
EP3601240B1 (en) 2021-08-04
JP7041687B2 (ja) 2022-03-24
JP2020512353A (ja) 2020-04-23

Similar Documents

Publication Publication Date Title
PH12021550167A1 (en) Heterobicyclic compounds for inhibiting the activity of shp2
PH12019550041A1 (en) Compounds and methods for ido and tdo modulation, and indications therefor
MX2021002978A (es) Lactamas biciclicas y metodos de uso de las mismas.
PH12017502090A1 (en) Heterocyclic amides as kinase inhibitors
PH12017500658B1 (en) Spirodiamine derivatives as aldosterone synthase inhibitors
MX2020005622A (es) Compuestos de indol sustituidos con arilo y heteroarilo.
MX2016011992A (es) Derivados de piperidina-diona.
TW201613872A (en) IRAK4 inhibiting agents
PH12016501440A1 (en) Novel heterocyclic compounds
UY36122A (es) ?derivados de pirrolidina-2,5-diona, composiciones farmacéuticas y métodos para usar como inhibidores ido1?
PH12019500664A1 (en) New isoxazolyl ether derivatives as gaba a alpha5 pam
PH12020500655A1 (en) Compounds
PH12018500268A1 (en) 2-amino-3-fluoro-3-(fluoromethyl)-6-methyl-6-phenyl-3,4,5,6-tetrahydropyridins as bace1 inhibitors
MX2015010775A (es) Benzoxazoles sustituidos y metodos para usarlos.
MX2016008499A (es) Derivados de arilsultamo como moduladores del receptor huerfano relacionado con el receptor de retinoide (rorc).
PH12020500105A1 (en) Bicyclic ketone compounds and methods of use thereof
MX2015001099A (es) Nuevos derivados biciclicos de piridina.
MX2019011517A (es) Proceso para producir analogos de anillo de arilomicina.
MX2021001565A (es) Inhibidores tipo indol y azaindol de enzimas peptidil arginina deiminasas (pad).
MX2022000550A (es) Imidazopirimidinas como inhibidores de eed y uso de estas.
PH12016501613A1 (en) Pyrazines modulators of gpr6
MX2015016400A (es) Nuevos compuestos de 3,4-dihidro-2h-isoquinolin-1-ona y 2,3-dihidro-isoindol-1-ona.
PH12018500668A1 (en) Therapeutic compounds and methods of use thereof
MX2019002017A (es) Derivados de sofosbuvir para el tratamiento de la hepatitis c.
SG10201810263QA (en) Nampt inhibitors and methods